ICCC vs SBUX · rev $17.5M vs P/E 76, rev $37.18B
ImmuCell Corporation (ICCC) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian Niccol.
Latest reported ICCC revenue for 2026-06-30 was $17.5M. Net income was $3.8M. Revenue was up 69.4% from 2026-03-31 to 2026-06-30. ICCC currently screens at market cap $58.9M.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
ICCC currently screens at market cap $58.9M. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the ICCC and SBUX stock pages for the full models.
Not investment advice.